HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.

Abstract
Of 3,004 gram-negative bacilli collected from intra-abdominal infections in the Asia-Pacific region during 2007, 42.2% and 35.8% of Escherichia coli and Klebsiella spp., respectively, were extended-spectrum beta-lactamase (ESBL) positive. Moreover ESBL rates in India for E. coli, Klebsiella pneumoniae, and Klebsiella oxytoca were 79.0%, 69.4%, and 100%, respectively. ESBL-positive E. coli rates were also relatively high in China (55.0%) and Thailand (50.8%). Ertapenem and imipenem were the most active drugs tested, inhibiting over 90% of all species, including ESBL-positive isolates with the exception of Pseudomonas aeruginosa isolates (<90% susceptible to all study drugs) and ESBL-positive Klebsiella pneumoniae isolates (<90% susceptible to all study drugs except imipenem). Quinolones achieved 90% inhibition levels only against ESBL-negative K. pneumoniae and ESBL-negative K. oxytoca. A decline in ampicillin-sulbactam activity was noted, with only 34.5% of all Enterobacteriaceae inhibited in this study.
AuthorsStephen P Hawser, Samuel K Bouchillon, Daryl J Hoban, Robert E Badal, Po-Ren Hsueh, David L Paterson
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 53 Issue 8 Pg. 3280-4 (Aug 2009) ISSN: 1098-6596 [Electronic] United States
PMID19506060 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Quinolones
  • beta-Lactams
  • Imipenem
  • beta-Lactamases
  • Ertapenem
Topics
  • Anti-Bacterial Agents (pharmacology)
  • China
  • Drug Resistance, Bacterial
  • Ertapenem
  • Escherichia coli (drug effects, enzymology)
  • Gram-Negative Bacteria (drug effects, enzymology, isolation & purification)
  • Gram-Negative Bacterial Infections (microbiology)
  • Imipenem (pharmacology)
  • India
  • Klebsiella (drug effects, enzymology)
  • Quinolones (pharmacology)
  • Thailand
  • beta-Lactamases (metabolism)
  • beta-Lactams (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: